In this sense, AOSD seems to be mainly driven by an IL-1β-, IL-18-, and IL-6-mediated immune response, evidenced by great successes of IL-1- and IL-6-blockade (14, 15). This evidence concerns the gene IL1B and adult-onset Still disease.